AACR IO 2026 Keynote Highlights: Cancer Vaccines Are Here, and Upgrading T Cells To Thrive in the Tumor Microenvironment
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
At the AACR Annual Meeting 2025, experts offered strategies on how to overcome the challenges within the oncology drug...
The latest edition of From the Bench features creative cancer research, including making tumors seem like pig organs, starving...
At the AACR Annual Meeting 2025, researchers and patient advocates shared insights into the impact of NIH funding cuts...
Learn how a Gleason score is calculated to help determine the aggressiveness of prostate cancer, and how it could...
Research unveiled at the AACR Annual Meeting 2025 highlighted advances in blood-based liquid biopsy tests to help improve cancer...
Clinical trial results reported at the AACR Annual Meeting 2025 showcased new therapeutic approaches for non-small cell lung cancer....
During the Presidential Select Symposium at the AACR Annual Meeting 2025, Patricia M. LoRusso, DO, PhD(h), FAACR, led a...
For April 2025, the editors of AACR's 10 journals highlighted studies on evolution in glioblastoma, new cancer treatment approaches,...
Takeaways from the final day of the AACR Annual Meeting 2025 included the biggest discoveries presented, a look at...
Adding pembrolizumab before and after surgery to standard of care improved outcomes in patients with previously untreated head and...